Small Bowel Enteroscope Market to Witness Robust Growth at 8-9% CAGR, Surpassing USD 500 Million by 2022

The global small bowel enteroscope market is poised for significant growth, projected to rise from its current valuation of USD 500 million in 2022 to over USD 1 billion by 2032, at a CAGR of 8-9% during the forecast period. This growth is fueled by the increasing adoption of advanced endoscopic technologies and the growing prevalence of gastrointestinal (GI) disorders worldwide.

Market Growth Drivers

1. Rising Incidence of Gastrointestinal Disorders
With a growing prevalence of gastrointestinal conditions such as celiac disease, Crohn's disease, and small bowel tumors, the demand for diagnostic and interventional devices like small bowel enteroscopes is on the rise. The ability of small bowel enteroscopes to provide a complete view of the small intestine enables more accurate diagnoses, early detection of GI disorders, and effective therapeutic interventions.

2. Technological Advancements in Enteroscopy
Advancements in interventional and visualization technologies have led to the development of high-definition imaging enteroscopes. Unlike traditional devices, modern enteroscopes offer enhanced clarity, higher resolution, and the ability to access deeper sections of the bowel. The advent of double-balloon and capsule endoscopy has revolutionized small bowel diagnostics, and continuous improvements are expected to drive further demand.

3. Increasing Use of Minimally Invasive Procedures
Minimally invasive procedures are preferred by both patients and healthcare providers due to shorter recovery times, reduced risk of infection, and less post-operative discomfort. Enteroscopy, being a non-surgical procedure, offers an efficient alternative to invasive diagnostic procedures. This shift toward minimally invasive endoscopic procedures is a major contributor to the growth of the small bowel enteroscope market.

4. Rising Demand for Interventional Therapy
Small bowel enteroscopes not only aid in diagnosis but also facilitate interventional treatments such as polyp removal, biopsy, and control of gastrointestinal bleeding. The ability to visualize and treat simultaneously enhances the efficiency of endoscopic procedures, leading to increased adoption in hospitals, ambulatory surgical centers, and specialty clinics.

5. Increased Awareness and Early Diagnosis
With the rising incidence of colorectal cancer and gastrointestinal complications, there is growing awareness about the importance of early diagnosis and treatment. Small bowel enteroscopy plays a key role in screening for cancer, bleeding sources, and abnormal growths in the small intestine. This growing awareness, along with advancements in screening methods, is expected to boost market growth.

Request a Sample of this Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-9579

Market Trends

1. Adoption of Capsule Endoscopy
The development of capsule endoscopy has introduced a novel way to visualize the small bowel. Unlike traditional endoscopes, capsule endoscopes are swallowed and pass naturally through the gastrointestinal tract, capturing images as they travel. This technology has become a preferred option for patients due to its non-invasive nature. Capsule endoscopy is expected to impact market growth as it offers patients a more comfortable alternative to conventional enteroscopy.

2. Increased Use of Double-Balloon Enteroscopes
Double-balloon enteroscopy (DBE) is increasingly adopted due to its ability to access the entire small bowel, which is not achievable with traditional endoscopes. DBE allows healthcare providers to diagnose and treat conditions deep within the small bowel, making it essential for the management of diseases such as obscure gastrointestinal bleeding and intestinal tumors. This technique is becoming a gold standard for small bowel diagnosis, driving demand for advanced enteroscopes.

3. Integration of Artificial Intelligence (AI) in Endoscopy
The integration of AI-based image recognition in enteroscopy has enabled faster and more accurate detection of polyps, tumors, and ulcers. AI-powered enteroscopes can now analyze images in real time, alerting medical professionals to possible abnormalities. This technology is expected to drive growth as AI-enabled devices become standard tools for endoscopy procedures.

4. Growing Adoption in Emerging Markets
The adoption of small bowel enteroscopy is expanding in emerging markets due to rising healthcare awareness, increased government support, and growing healthcare expenditures. Countries like India, China, and Brazil are witnessing rising demand for minimally invasive gastrointestinal procedures, creating significant growth potential for manufacturers.

Market Competition

Leading players present in the global small bowel enteroscope market include Pentax Medical, Olympus Corporation, and FUJIFILM Holdings America Corporation among others.

The market is fairly competitive with key companies in the market engaged in developing their portfolio of new enteroscope products and adopting a commercialization strategy. Leading manufacturers are currently carrying out multiple clinical trials related to other indications of small bowel enteroscope to expand their product portfolio and strengthen their position in the market.

Key Companies Profiled

Pentax Medical; Olympus Corporation; FUJIFILM Holdings America Corporation

Key Segments Profiled in the Small Bowel Enteroscope Market Survey

By Indication:

Obscure gastrointestinal bleeding
Small bowel tumors
Polyposis syndromes
Dilation of small bowel stenosis

By End User:

Hospitals
Clinics
Diagnostics Laboratories
Others

By Region:

North America (USA, Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)

Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:

Gene Editing Tool Market - https://www.futuremarketinsights.com/reports/gene-editing-tools-market

Clinical Oncology Next-generation Sequencing Market -
https://www.futuremarketinsights.com/reports/clinical-oncology-next-generation-sequencing-market

HDL Cholesterol Kits Market - https://www.futuremarketinsights.com/reports/hdl-cholesterol-kits-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.